{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-000056","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2024-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.539010+00:00","generated_at":"2026-06-07T05:25:03.027286+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Jasper Therapeutics announces 1-for-10 reverse stock split effective Jan 4, 2024","bullets":["Reverse split ratio set at 1-for-10, effective 12:01 a.m. ET on Jan 4, 2024.","Outstanding shares reduced from ~111.6M to ~11.2M; par value unchanged.","Intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement.","No fractional shares; cash in lieu based on Jan 3 closing price.","Warrants adjusted: 10 warrants exercisable for 1 share at $115.00 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-000056","json":"https://secwatch.observer/filing/0001213900-24-000056.json","markdown":"https://secwatch.observer/filing/0001213900-24-000056.md","text":"https://secwatch.observer/filing/0001213900-24-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390024000056/0001213900-24-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390024000056/ea190805-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T05:25:03.027286+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}